PHARMACOKINETICS OF CONCOMITANTLY ADMINISTERED FOSCARNET AND ZIDOVUDINE FOR TREATMENT OF HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION (AIDS CLINICAL-TRIALS GROUP PROTOCOL-053)

被引：15
|
作者：
AWEEKA, FT
GAMBERTOGLIO, JG
VANDERHORST, C
RAASCH, R
JACOBSON, MA
机构：
[1] UNIV CALIF SAN FRANCISCO,DEPT MED,SAN FRANCISCO,CA 94143
[2] UNIV N CAROLINA,DEPT MED,CHAPEL HILL,NC 27599
[3] UNIV N CAROLINA,SCH PHARM,CHAPEL HILL,NC 27599
[4] SAN FRANCISCO GEN HOSP,MED SERV,SAN FRANCISCO,CA 94110
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1992年 / 36卷 / 08期
关键词：
D O I：
10.1128/AAC.36.8.1773
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
Foscarnet and zidovudine (ZDV) pharmacokinetic parameters were not altered in five patients receiving 14 days of concomitant therapy. Foscarnet clearance in plasma averaged (+/- standard deviation) 0.16 +/- 0.03 and 0.13 +/- 0.05 liter/h/kg of body weight in the absence and presence of ZDV. ZDV parameters were also not significantly altered, with a mean (+/- standard deviation) oral clearance of 2.7 +/- 1.0 and 2.6 +/- 0.8 liter/h/kg for the 2 study days, respectively.
引用
收藏
页码：1773 / 1778
页数：6
相关论文
共 50 条
  • [1] PHARMACOKINETICS AND BIOAVAILABILITY OF ZIDOVUDINE AND ITS GLUCURONIDATED METABOLITE IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION AND HEPATIC-DISEASE (AIDS CLINICAL-TRIALS GROUP PROTOCOL-062)
    MOORE, KHP
    RAASCH, RH
    BROUWER, KLR
    OPHEIM, K
    CHEESEMAN, SH
    EYSTER, E
    LEMON, SM
    VANDERHORST, CM
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (12) : 2732 - 2737
  • [2] INVIVO ADDITIVE ANTIRETROVIRAL EFFECT OF COMBINED ZIDOVUDINE AND FOSCARNET THERAPY FOR HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION (ACTG PROTOCOL 053)
    JACOBSON, MA
    VANDERHORST, C
    CAUSEY, DM
    DEHLINGER, M
    HAFNER, R
    MILLS, J
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (06): : 1219 - 1222
  • [3] ZIDOVUDINE FOR THE REDUCTION OF PERINATAL HUMAN-IMMUNODEFICIENCY-VIRUS TRANSMISSION - PEDIATRIC AIDS CLINICAL-TRIALS GROUP PROTOCOL-076 - RESULTS AND TREATMENT RECOMMENDATIONS
    CONNOR, EM
    MOFENSON, LM
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1995, 14 (06) : 536 - 541
  • [4] PHARMACOKINETICS (PK) OF CONCOMITANTLY ADMINISTERED FOSCARNET (F) AND ZIDOVUDINE (Z) IN THE TREATMENT OF PATIENTS WITH AIDS
    AWEEKA, FT
    GAMBERTOGLIO, J
    VANDERHORST, C
    JACOBSON, MA
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1991, 49 (02) : 198 - 198
  • [5] FOSCARNET FOR TREATMENT OF HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
    COLLIER, AC
    [J]. ANTIVIRAL CHEMOTHERAPY : NEW DIRECTIONS FOR CLINICAL APPLICATION AND RESEARCH, VOL 2, 1989, : 319 - 326
  • [6] USE OF VIROLOGICAL ASSAYS FOR DETECTION OF HUMAN-IMMUNODEFICIENCY-VIRUS IN CLINICAL-TRIALS - RECOMMENDATIONS OF THE AIDS CLINICAL-TRIALS GROUP VIROLOGY COMMITTEE
    HAMMER, S
    CRUMPACKER, C
    DAQUILA, R
    JACKSON, B
    LATHEY, J
    LIVNAT, D
    REICHELDERFER, P
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1993, 31 (10) : 2557 - 2564
  • [7] RECOMBINANT-HUMAN-ERYTHROPOIETIN IN THE TREATMENT OF ANEMIA ASSOCIATED WITH HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) INFECTION AND ZIDOVUDINE THERAPY - OVERVIEW OF 4 CLINICAL-TRIALS
    HENRY, DH
    BEALL, GN
    BENSON, CA
    CAREY, J
    CONE, LA
    ERON, LJ
    FIALA, M
    FISCHL, MA
    GABIN, SJ
    GOTTLIEB, MS
    GALPIN, JE
    GROOPMAN, JE
    HOOTON, TM
    JEMSEK, JG
    LEVINE, RL
    MILES, SA
    RINEHART, JJ
    RIOS, A
    ROBBINS, WJ
    RUCKDESCHEL, JC
    SMITH, JA
    SPRUANCE, SL
    STARRETT, B
    TONEY, J
    ZALUSKY, R
    ABELS, RI
    BRYANT, EC
    LARHOLT, KM
    SAMPSON, AR
    RUDNICK, SA
    [J]. ANNALS OF INTERNAL MEDICINE, 1992, 117 (09) : 739 - 748
  • [8] ZIDOVUDINE TREATMENT OF AN INFANT WITH CONGENITAL HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
    MILLARD, DD
    CHADWICK, EG
    YOGEV, R
    MODLIN, JF
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1990, 9 (12) : 929 - 931
  • [9] ADMINISTRATION OF ZIDOVUDINE FOR TREATMENT OF INFECTION DUE TO HUMAN-IMMUNODEFICIENCY-VIRUS
    BLOTT, KW
    [J]. REVIEWS OF INFECTIOUS DISEASES, 1991, 13 (01): : 186 - 186
  • [10] PHARMACOKINETICS OF ZIDOVUDINE ADMINISTERED INTRAVENOUSLY AND ORALLY IN CHILDREN WITH HUMAN IMMUNODEFICIENCY VIRUS-INFECTION
    BALIS, FM
    PIZZO, PA
    EDDY, J
    WILFERT, C
    MCKINNEY, R
    SCOTT, G
    MURPHY, RF
    JAROSINSKI, PF
    FALLOON, J
    POPLACK, DG
    [J]. JOURNAL OF PEDIATRICS, 1989, 114 (05): : 880 - 884
12345